Tianjin Tasly Shengtai Pharmaceutical

Tasly Shengtai Pharmaceutical is a subsidiary of the Tasly Pharmaceutical Group, specializing in the research, development, and large-scale manufacturing of chemical drugs and high-end formulations. The company operates advanced production facilities in Tianjin that meet international quality standards, including US FDA and EU GMP certifications, facilitating the export of its products to global markets. Its portfolio primarily focuses on oncology, cardiovascular, and metabolic diseases, with a notable emphasis on generic versions of complex small molecule therapies. Tasly Shengtai serves as a key internationalization platform for the broader Tasly Group, bridging Chinese pharmaceutical manufacturing with Western regulatory requirements.